Atlas Trials

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Clinical trial NCT00414531 · COMPLETED

Trial details

NCT number
NCT00414531
Sponsor
University of Oslo School of Pharmacy
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Myotoxicity of Atorvastatin Treatment
Start date
2005-05-01
Primary completion
2009-06-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.